AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca total Scope 1 & Scope 2 (market-based) GHG emissions (tCO2e)
Sustainability Data Annex — Ambition Zero Carbon (Scope 1 & 2 GHG Emissions)
Latest, FY2025
73,903
Period ended Dec 31, 2025
Change on a year earlier
-47.1%
139,594 in FY2024
History
5 years
Since FY2015
Sources
2
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total Scope 1 & Scope 2 (market-based) GHG emissions (tCO2e) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 73,903 | -47.1% | Sustainability Data Annex 2025 ↗ |
| FY2024 | Dec 31, 2024 | 139,594 | -30.5% | Sustainability Data Annex 2025 ↗ |
| FY2023 | Dec 31, 2023 | 200,838 | -21.6% | Sustainability Data Annex 2025 ↗ |
| FY2022 | Dec 31, 2022 | 256,194 | – | Sustainability Data Annex 2024 ↗ |
| FY2015 | Dec 31, 2015 | 620,818 | – | Sustainability Data Annex 2025 ↗ |
Breakdown
What makes up total scope 1 & scope 2 (market-based) ghg emissions (tco2e)
- Total Scope 1 direct GHG emissions (tCO2e)62,587 · FY2025
- Scope 2 indirect GHG emissions — Market-based (tCO2e)11,316 · FY2025
- Scope 2 indirect GHG emissions — Location-based (tCO2e)241,023 · FY2025
- Scope 1 & 2 GHG emissions intensity (tCO2e per $M Total Revenue)1.26 · FY2025
- Biogenic CO2 emissions (tCO2e)105,850 · FY2025
Cite this data
StockData. (2026). AstraZeneca Total Scope 1 & Scope 2 (market-based) GHG emissions (tCO2e), annual FY2015–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/esg_scope12_market
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.